Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Three-Dimensional Craniofacial Bone Reconstruction With SmartBone on Demand.

Facciuto E, Grottoli CF, Mattarocci M, Illiano F, Compagno M, Ferracini R, Perale G.

J Craniofac Surg. 2019 May/Jun;30(3):739-741. doi: 10.1097/SCS.0000000000005277.

PMID:
30807480
2.

Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations.

Roato I, Belisario DC, Compagno M, Lena A, Bistolfi A, Maccari L, Mussano F, Genova T, Godio L, Perale G, Formica M, Cambieri I, Castagnoli C, Robba T, Felli L, Ferracini R.

Int Orthop. 2019 Jan;43(1):15-23. doi: 10.1007/s00264-018-4192-4. Epub 2018 Oct 11.

PMID:
30311059
3.

Scaffolds as Structural Tools for Bone-Targeted Drug Delivery.

Ferracini R, Martínez Herreros I, Russo A, Casalini T, Rossi F, Perale G.

Pharmaceutics. 2018 Aug 8;10(3). pii: E122. doi: 10.3390/pharmaceutics10030122. Review.

4.

Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration.

Roato I, Belisario DC, Compagno M, Verderio L, Sighinolfi A, Mussano F, Genova T, Veneziano F, Pertici G, Perale G, Ferracini R.

Stem Cells Int. 2018 Apr 29;2018:4126379. doi: 10.1155/2018/4126379. eCollection 2018.

5.

Osteogenic Differentiation Modulates the Cytokine, Chemokine, and Growth Factor Profile of ASCs and SHED.

Mussano F, Genova T, Petrillo S, Roato I, Ferracini R, Munaron L.

Int J Mol Sci. 2018 May 14;19(5). pii: E1454. doi: 10.3390/ijms19051454.

6.

Does metal porosity affect metal ion release in blood and urine following total hip arthroplasty? A short term study.

Bistolfi A, Cimino A, Lee GC, Ferracini R, Maina G, Berchialla P, Massazza G, Massè A.

Hip Int. 2018 Sep;28(5):522-530. doi: 10.1177/1120700018762167. Epub 2018 May 9.

PMID:
29742937
7.

Tripled semitendinosus with single harvesting is as effective but less invasive compared to standard gracilis-semitendinosus harvesting.

Drocco L, Camazzola D, Ferracini R, Lustig S, Ravera L, Graziano E, Massè A, Bistolfi A.

Muscles Ligaments Tendons J. 2018 Apr 16;7(4):564-572. doi: 10.11138/mltj/2017.7.4.564. eCollection 2017 Oct-Dec.

8.

Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.

Roato I, Ferracini R.

Cancers (Basel). 2018 Feb 20;10(2). pii: E56. doi: 10.3390/cancers10020056. Review.

9.

Evaluation of the Effectiveness of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty: A Meta-Analysis.

Bistolfi A, Zanovello J, Ferracini R, Allisiardi F, Lioce E, Magistroni E, Berchialla P, Da Rold I, Massazza G.

Am J Phys Med Rehabil. 2018 Feb;97(2):123-130. doi: 10.1097/PHM.0000000000000847.

PMID:
29016401
10.

Adipose Derived-Mesenchymal Stem Cells Viability and Differentiating Features for Orthopaedic Reparative Applications: Banking of Adipose Tissue.

Roato I, Alotto D, Belisario DC, Casarin S, Fumagalli M, Cambieri I, Piana R, Stella M, Ferracini R, Castagnoli C.

Stem Cells Int. 2016;2016:4968724. doi: 10.1155/2016/4968724. Epub 2016 Nov 29.

11.

C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.

D'Amico L, Belisario D, Migliardi G, Grange C, Bussolati B, D'Amelio P, Perera T, Dalmasso E, Dalle Carbonare L, Godio L, Comoglio P, Trusolino L, Ferracini R, Roato I.

Oncotarget. 2016 Jul 19;7(29):45525-45537. doi: 10.18632/oncotarget.9997.

12.

Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma.

Castella B, Foglietta M, Sciancalepore P, Rigoni M, Coscia M, Griggio V, Vitale C, Ferracini R, Saraci E, Omedé P, Riganti C, Palumbo A, Boccadoro M, Massaia M.

Oncoimmunology. 2015 May 26;4(11):e1047580. eCollection 2015 Nov.

13.

Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

Bertolini G, D'Amico L, Moro M, Landoni E, Perego P, Miceli R, Gatti L, Andriani F, Wong D, Caserini R, Tortoreto M, Milione M, Ferracini R, Mariani L, Pastorino U, Roato I, Sozzi G, Roz L.

Cancer Res. 2015 Sep 1;75(17):3636-49. doi: 10.1158/0008-5472.CAN-14-3781. Epub 2015 Jul 3.

14.

The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.

Foglietta M, Castella B, Mariani S, Coscia M, Godio L, Ferracini R, Ruggeri M, Muccio V, Omedé P, Palumbo A, Boccadoro M, Massaia M.

Haematologica. 2014 Oct;99(10):1605-10. doi: 10.3324/haematol.2014.105866. Epub 2014 Jun 27.

15.

DKK-1 in prostate cancer diagnosis and follow up.

D'Amelio P, Roato I, Oderda M, Soria F, Zitella A, Ferracini R, Mengozzi G, Gontero P, Isaia GC.

BMC Clin Pathol. 2014 Mar 21;14(1):11. doi: 10.1186/1472-6890-14-11.

16.

CD38 and bone marrow microenvironment.

Chillemi A, Zaccarello G, Quarona V, Lazzaretti M, Martella E, Giuliani N, Ferracini R, Pistoia V, Horenstein AL, Malavasi F.

Front Biosci (Landmark Ed). 2014 Jan 1;19:152-62. Review.

PMID:
24389178
17.

Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature.

D'Amico L, Patanè S, Grange C, Bussolati B, Isella C, Fontani L, Godio L, Cilli M, D'Amelio P, Isaia G, Medico E, Ferracini R, Roato I.

Br J Cancer. 2013 Jun 25;108(12):2525-36. doi: 10.1038/bjc.2013.271.

18.

Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients.

Leite SC, Corrêa DG, Doring TM, Kubo TT, Netto TM, Ferracini R, Ventura N, Bahia PR, Gasparetto EL.

J Magn Reson Imaging. 2013 Dec;38(6):1488-93. doi: 10.1002/jmri.24129. Epub 2013 Apr 4.

PMID:
23559497
19.

Bone metastases in gastric cancer follow a RANKL-independent mechanism.

D'Amico L, Satolli MA, Mecca C, Castiglione A, Ceccarelli M, D'Amelio P, Garino M, De Giuli M, Sandrucci S, Ferracini R, Roato I.

Oncol Rep. 2013 Apr;29(4):1453-8. doi: 10.3892/or.2013.2280. Epub 2013 Feb 6.

20.

The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.

Dani N, Olivero M, Mareschi K, van Duist MM, Miretti S, Cuvertino S, Patané S, Calogero R, Ferracini R, Scotlandi K, Fagioli F, Di Renzo MF.

J Bone Miner Res. 2012 Jun;27(6):1322-34. doi: 10.1002/jbmr.1578.

21.

Teriparatide increases the maturation of circulating osteoblast precursors.

D'Amelio P, Tamone C, Sassi F, D'Amico L, Roato I, Patanè S, Ravazzoli M, Veneziano L, Ferracini R, Pescarmona GP, Isaia GC.

Osteoporos Int. 2012 Apr;23(4):1245-53. doi: 10.1007/s00198-011-1666-2. Epub 2011 May 27.

22.

Iloprost modulates the immune response in systemic sclerosis.

D'Amelio P, Cristofaro MA, D'Amico L, Veneziano L, Roato I, Sassi F, Bisignano G, Saracco M, Pellerito R, Patanè S, Ferracini R, Pescarmona GP, Isaia GC.

BMC Immunol. 2010 Dec 15;11:62. doi: 10.1186/1471-2172-11-62.

23.

Bone impairment in phenylketonuria is characterized by circulating osteoclast precursors and activated T cell increase.

Roato I, Porta F, Mussa A, D'Amico L, Fiore L, Garelli D, Spada M, Ferracini R.

PLoS One. 2010 Nov 30;5(11):e14167. doi: 10.1371/journal.pone.0014167.

24.

Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures.

D'Amelio P, Roato I, D'Amico L, Veneziano L, Suman E, Sassi F, Bisignano G, Ferracini R, Gargiulo G, Castoldi F, Pescarmona GP, Isaia GC.

Osteoporos Int. 2011 Nov;22(11):2869-77. doi: 10.1007/s00198-010-1496-7. Epub 2010 Nov 30.

25.

Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues.

Roato I, Caldo D, D'Amico L, D'Amelio P, Godio L, Patanè S, Astore F, Grappiolo G, Boggio M, Scagnelli R, Molfetta L, Ferracini R.

Biomaterials. 2010 Oct;31(29):7519-25. doi: 10.1016/j.biomaterials.2010.06.027. Epub 2010 Jul 17.

PMID:
20638717
26.

Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).

Lolli ML, Rolando B, Tosco P, Chaurasia S, Di Stilo A, Lazzarato L, Gorassini E, Ferracini R, Oliaro-Bosso S, Fruttero R, Gasco A.

Bioorg Med Chem. 2010 Apr 1;18(7):2428-38. doi: 10.1016/j.bmc.2010.02.058. Epub 2010 Mar 1.

PMID:
20299227
27.

Bone invading NSCLC cells produce IL-7: mice model and human histologic data.

Roato I, Caldo D, Godio L, D'Amico L, Giannoni P, Morello E, Quarto R, Molfetta L, Buracco P, Mussa A, Ferracini R.

BMC Cancer. 2010 Jan 12;10:12. doi: 10.1186/1471-2407-10-12.

28.

Osteoclasts are active in bone forming metastases of prostate cancer patients.

Roato I, D'Amelio P, Gorassini E, Grimaldi A, Bonello L, Fiori C, Delsedime L, Tizzani A, De Libero A, Isaia G, Ferracini R.

PLoS One. 2008;3(11):e3627. doi: 10.1371/journal.pone.0003627. Epub 2008 Nov 3.

29.

Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria.

Porta F, Roato I, Mussa A, Repici M, Gorassini E, Spada M, Ferracini R.

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S339-42. doi: 10.1007/s10545-008-0907-9. Epub 2008 Oct 17.

PMID:
18923919
30.

A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.

Miretti S, Roato I, Taulli R, Ponzetto C, Cilli M, Olivero M, Di Renzo MF, Godio L, Albini A, Buracco P, Ferracini R.

PLoS One. 2008 Mar 19;3(3):e1828. doi: 10.1371/journal.pone.0001828.

31.

Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer.

Roato I, Gorassini E, Buffoni L, Lyberis P, Ruffini E, Bonello L, Baldi I, Ciuffreda L, Mussa A, Ferracini R.

Lung Cancer. 2008 Jul;61(1):109-16. Epub 2007 Dec 3.

PMID:
18061306
32.

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.

Piva R, Ruggeri B, Williams M, Costa G, Tamagno I, Ferrero D, Giai V, Coscia M, Peola S, Massaia M, Pezzoni G, Allievi C, Pescalli N, Cassin M, di Giovine S, Nicoli P, de Feudis P, Strepponi I, Roato I, Ferracini R, Bussolati B, Camussi G, Jones-Bolin S, Hunter K, Zhao H, Neri A, Palumbo A, Berkers C, Ovaa H, Bernareggi A, Inghirami G.

Blood. 2008 Mar 1;111(5):2765-75. Epub 2007 Dec 5.

33.

IL-7 modulates osteoclastogenesis in patients affected by solid tumors.

Roato I, Gorassini E, Brunetti G, Grano M, Ciuffreda L, Mussa A, Ferracini R.

Ann N Y Acad Sci. 2007 Nov;1117:377-84. Epub 2007 Jun 21.

PMID:
17584976
34.

IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.

Roato I, Brunetti G, Gorassini E, Grano M, Colucci S, Bonello L, Buffoni L, Manfredi R, Ruffini E, Ottaviani D, Ciuffreda L, Mussa A, Ferracini R.

PLoS One. 2006 Dec 27;1:e124.

35.

MET overexpression turns human primary osteoblasts into osteosarcomas.

Patanè S, Avnet S, Coltella N, Costa B, Sponza S, Olivero M, Vigna E, Naldini L, Baldini N, Ferracini R, Corso S, Giordano S, Comoglio PM, Di Renzo MF.

Cancer Res. 2006 May 1;66(9):4750-7.

36.

Anaplasia is rare and does not influence prognosis in adult medulloblastoma.

Giordana MT, D'Agostino C, Pollo B, Silvani A, Ferracini R, Paiolo A, Ghiglione P, Chiò A.

J Neuropathol Exp Neurol. 2005 Oct;64(10):869-74.

PMID:
16215458
37.

Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.

Roato I, Grano M, Brunetti G, Colucci S, Mussa A, Bertetto O, Ferracini R.

FASEB J. 2005 Feb;19(2):228-30. Epub 2004 Nov 18.

PMID:
15550550
38.

Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.

Cagliero E, Ferracini R, Morello E, Scotlandi K, Manara MC, Buracco P, Comandone A, Baroetto Parisi R, Baldini N.

Oncol Rep. 2004 Nov;12(5):1023-31.

PMID:
15492788
39.

Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma.

Coltella N, Manara MC, Cerisano V, Trusolino L, Di Renzo MF, Scotlandi K, Ferracini R.

FASEB J. 2003 Jun;17(9):1162-4. Epub 2003 Apr 22.

PMID:
12709413
40.
41.

Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.

Schiffer D, Ferracini R, Cavalla P.

Anticancer Res. 2001 Jul-Aug;21(4A):2531-5.

PMID:
11724318
42.

An atypical presentation of Paget's disease in an immunocompromised individual. A case report.

Sanders W, Bertolo S, Wunder JS, Kandel R, White L, Cialdella L, Ferracini R.

Chir Organi Mov. 1999 Oct-Dec;84(4):375-9. English, Italian.

PMID:
11569005
43.

Isolated hemangioblastoma of the filum terminale. Case report.

Farneti M, Ferracini R, Migliore A, Trapella G, Veronesi V.

J Neurosurg Sci. 2001 Mar;45(1):58-62.

PMID:
11466510
44.

Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs.

Morello E, Buracco P, Martano M, Peirone B, Capurro C, Valazza A, Cotto D, Ferracini R, Sora M.

J Small Anim Pract. 2001 Feb;42(2):61-6.

PMID:
11263699
45.

The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors.

Ferracini R, Scotlandi K, Cagliero E, Acquarone F, Olivero M, Wunder J, Baldini N.

J Cell Physiol. 2000 Aug;184(2):191-6.

PMID:
10867643
46.

MET oncogene aberrant expression in canine osteosarcoma.

Ferracini R, Angelini P, Cagliero E, Linari A, Martano M, Wunder J, Buracco P.

J Orthop Res. 2000 Mar;18(2):253-6.

47.

Assessment of vascularized fibular graft one year after reconstruction of the wrist after excision of a giant-cell tumour.

Ferracini R, Gino G, Battiston B, Linari A, Franz R, Bertolo S.

J Hand Surg Br. 1999 Aug;24(4):497-500.

PMID:
10473167
48.

Acetabular osteoblastoma: description of a case.

Ferracini R, Zorzan A, Mauro PP, Massè G, Masterson EL.

Chir Organi Mov. 1998 Oct-Dec;83(4):413-7. English, Italian.

PMID:
10369022
49.
50.

Distal ulnar tumours. Results of management by en bloc resection in nine patients and review of the literature.

Ferracini R, Masterson EL, Bell RS, Wunder JS.

J Hand Surg Br. 1998 Aug;23(4):517-21.

PMID:
9726558

Supplemental Content

Loading ...
Support Center